Publication date: Jul 01, 2025
The impact of remdesivir on renal and liver functions remains a matter of concern in advanced COVID-19 patients with high illness severity and presence of viral load. The laboratory results of the 114 patients (males 55. 8%, age 71 (59; 77) years) with a detectable viral load treated with remdesivir were compared with the controls. Baseline plasmatic creatinine (PCr) 0. 9). Changes of PCr were independent of the remdesivir therapy, the statistically significant confounders were baseline PCr levels (p
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | viral load |
| drug | DRUGBANK | Creatinine |
| drug | DRUGBANK | Adenosine phosphate |
| drug | DRUGBANK | L-Alanine |
| drug | DRUGBANK | Urea |
Original Article
(Visited 3 times, 1 visits today)